Ogimura Takashi Special Prize
- Yuichi Ishikawa
- [Nagoya University Graduate School of Medicine.Department of Hematology and Oncology,Lecturer]
- “Mechanisms of Therapeutic Resistance in Acute Myeloid Leukemia and Development of Novel Therapevtic Strategies ”
Takaku Fumimaro Award
- Tsukasa Nabekura
- [Aichi Cancer Center Research Jnstitute , Division of Immune Response ,Chref ]
- “Elucichation of molecular mechanisms lyuhich immunomodulatory drugs actuate anti-tumor actiuity of NKcell and its application ”
TS Alfresa Award
- Tatsuya Morishima
- [Letermational Reserch Center for Medical Seinces(IRCMS) Kumamoto University,
Lecturer , Wakakusu Reseach(Ir,PI)]
- “The role of tRNA moditication in myelodysplastic syndromes ”
Shimizu Yasunobu Award
- Takahiro Kamiya
- [Institute of Science Tokyo, Deprtmant of Pediatries and Developmental Biology, Associate Professor ]
- “Research toward clinical application of fratricide-resistantCD7-CAR T cell therapy in Japan”
Credit Saison Award
- Haruko Shima
- [Keiou Universty, Department of Pediatrics, Associate Professor]
- “ REST Trial : Reduce and Stop Tyrosine Kinase lnhibitors in Pediatric Chronic
Phase-Chronic Myeloid Leukemia ”
Ite Yukiko Award
- Shintaro Watanuki
- [Department of Cell Fafe Biology and Stem Cell Medicine,Tohoku University graduate School of Medicine, Associate Professor ]
- “Elucidating Metabolic Regulator in Hematologic madognactes and Developing Novel,Less Toxic therapies Using Servlet-Cell Real-Time Metabolic analysis”
Special Award --- Clinical Medicine Special Award（In no particular order）
- Shinya Fujita
- [National Institute for Global Health and Medicine Japan Institute for Health Security, Department of Stem Cell Biology, Postdoctoral fellow CJSPS Postdoctoral fellow]
- “Nociceptive herves facilitate stem/progenitor cell homin to bone marrow by regulating microcirculation and mechanosensing”
- Shinichi Tsujimoto
- [ Yokohama city university hospital lecturer]
- “ Development of a Novel Therapeutic Strategy Targeting the Metabolic Vulnerabilities of relapsed/refractory Acute myeloid leukemia.”
General Research Award（In no particular order）
- Yusuke Okamoto
- [Kyoto University Hospital , Department of Hematology ]
- “Development of Novel Therapeutic Strategies using iPS Models of ERCC6L2 and LIG4 Syndromes.”
- Junya Kuroda
- [kyoto Prefectural Univercity of Medicine, Division of Hematology and Oncology
,Professor]
- “Development of novel Immunotherapies by Clarifying how tumor cells, hematopoietic cell, and body enrivoment disrupt immune surveillance in blood cancers ”
- Hiroki Akiyama
- [Institute of Science Tokyo Hospital Department of Hematology ,Specially appointed assistant professor ]
- “Lipid droplet metabolism in hematopoietic and leukemic stem cells : implications for anti-leukemia therapy ”
- Jiro Kikuchi
- [Jichi Medical University Canter for Melecula Medicine,Associate Professor ]
- “ The role of Foxmi in multiple myeloma cell with Igt”
Research award for young researchers（In no particular order）
- Sakurako Suma
- [University of Tsukuba Hospital Deportment of Hematology , Assistant Professor]
- “Elucidation of the molecular basis of the extrandal niche in modal T follicular cell lymphoma and development of innovative niche-targeted therapies”
- Kimitoshi Goto
- [Nagoya City University. Graduate School of Medical Sciences, (phD student )]
- “Fxplorins Senetic Susceptibility in chronic active Epstein-Barr virus disease.”
- Shojiro Haji
- [ Graduate School of Medical Sciences, Kyushu University,Department of Medicine and Pio regulatory Science/Assistant Professor]
- “Investigation into the formation mechanisms and therapeutic targets of extramedullary disease , which are associated with poor prognosis in multiple myeloma”
- Tomohiro Yabushita
- [ IRCMS, Kumamoto University Research Scientist(JSPS Fellow PD)]
- “Mechanistic Elucidation of GVHD Regulation following Allogeneic Transplantation by Cranial Shielding”
Mainichi Award
- Reiji Fukano
- [Japan Children's Cancer Group, Lymphoma committee]
- “A multicenter prospective clinical trial to identify prognostic factors for establishing risk-adapted therapy in ALK-positive anaplastic large cell lymphoma”
Kobayashi Noboru Award
- Koichi Oshima
- [Japanese Pediatric Cancer Study Group ALL Committee]
- “A Multicentor, Open-Label,Phare 2a trial of Isatuximab plus chemotherapy in children,Adolescents,And Young Adults(AYA) with Relapsed or Refractory T-Cell
Acute lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma(
T-LBL)”
Award Recipient List of 2025-13
